The Munich-based Wacker Group is expanding collaboration with the Swiss market expansion services group DKSH in Southeast Asia. In addition to representing Wacker biotech products, DKSH will market pyrogenic silica and silicones for the cosmetic, food and pharmaceutical industries beginning in November.
Wacker transferred responsibility for marketing cyclodextrins, cystine and cysteine in Southeast Asia to DKSH in early October.
The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.
Samsung Biologics, a global contract development and manufacturing organization (CDMO), recently announced a series of manufacturing deals with a Europe-based pharmaceutical company.
The EU Green Deal has hurt Europe's industry. The Clean Industrial Deal aims to improve this, but a change of mindset at the Commission is needed.
Vynova Alkoxides GmbH is beginning the construction of a new alcoholates plant at Chemiepark Lülsdorf GmbH in Lülsdorf, Germany.
Eli Lilly plans to invest $27 billion to bolster its domestic medicine production across several therapeutic areas by building four new manufacturing sites in the US.
